Head Lice Clinical Trial
Official title:
A Randomised, Assessor Blinded "Proof of Concept" (Phase IIa) Clinical Study to Assess the Efficacy and Safety of Nice 'n Clear Head Lice Lotion in the Treatment of Head Lice
NCT number | NCT02974088 |
Other study ID # | CTNC01 |
Secondary ID | |
Status | Completed |
Phase | Phase 2 |
First received | |
Last updated | |
Start date | May 2006 |
Est. completion date | August 2006 |
Verified date | March 2024 |
Source | Medical Entomology Centre |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This was a Phase IIa randomised, assessor blinded, parallel group study in which half the participants were treated with Nice 'n Clear neem-based conditioning lotion plus combing with a head louse detection and removal comb and the remainder were treated with Nice 'n Clear plus combing with a normal grooming comb
Status | Completed |
Enrollment | 47 |
Est. completion date | August 2006 |
Est. primary completion date | August 2006 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 6 Months and older |
Eligibility | Inclusion Criteria: - Males and females who are found to have an active head louse infection, i.e. the presence of live lice. Detection combing will be done with a fine-toothed plastic detection comb, until at least one louse is found. - People who give written informed consent and/or, if the participant is below 16 years of age, whose guardian gives written informed consent to participate in the study. Assent/verbal assent forms will be required for those between the ages of 4 and 16 years of age. There is no maximum age limit. - Participants must be available for the duration of the study i.e. 15 days. Exclusion Criteria: - People who have been treated with other head louse products within the previous 2 weeks (14 days). - People who have undergone a course of antibiotic treatment using Cotrimoxazole, Trimethoprim or Septrin within the previous 4 weeks, or who are currently taking such a course. - People whose hair has been bleached, colour treated, or semi-permanently waved within the previous 2 weeks, this includes the use of semi-permanent colouring agents. Home use wash in/wash out colouring agents are acceptable. - People who have taken part in another clinical study within 4 weeks prior to entry to this one. - Females who are pregnant or breast-feeding. - Participants who have already taken part in this study. - People who have a known allergy to any of the ingredients of Nice 'n Clear Lotion (including allergy to Paraben preservatives) - Children under 6 months of age. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Medical Entomology Centre | Cambridge |
Lead Sponsor | Collaborator |
---|---|
Medical Entomology Centre | Leeds Health Protection Unit, Nelsons, PN Lee Statistics and Computing Ltd |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Participants Free From Head Louse Infestation as Assessed by Detection Combing | Recruitment at Day 0. Success of treatment = No lice present at Day 14 and no lice present at Day 10 | 15 days | |
Secondary | Difference in Number of Participants Free From Head Louse Infestation According to Comb Type Used | It was expected that the louse comb group would show a high level of success (elimination of infestation). The measure of efficacy of the neem-based lotion was the relative efficacy observed in the grooming comb group compared with the louse comb group | 15 days | |
Secondary | Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0 | Number of participants with application site reactions such as irritation, erythema, or other events related to treatment | 15 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00988533 -
A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age
|
Phase 1 | |
Completed |
NCT00672971 -
Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice
|
N/A | |
Completed |
NCT00858481 -
A Pilot Dose Ranging Study of Spinosad Creme Rinse
|
Phase 2 | |
Completed |
NCT03301649 -
Clinical Endpoint Study of Ivermectin 0.5% Lotion
|
Phase 3 | |
Completed |
NCT00995124 -
Trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion®, NeutraLice Advance® and Moov Head Lice Solution®) After a Single Application
|
Phase 4 | |
Completed |
NCT00994422 -
Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
|
Phase 2 | |
Completed |
NCT03337490 -
A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice
|
Phase 3 | |
Completed |
NCT06333054 -
Safety and Efficacy of a Head Lice Shampoo
|
N/A | |
Completed |
NCT02213055 -
Pediatric Head Lice Study Product Comparison
|
Phase 2 | |
Recruiting |
NCT05379114 -
Comparative Study for the Evaluation of a New Medical Device on the Treatment of Head Lice Infestation
|
N/A | |
Completed |
NCT03617926 -
A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.
|
N/A | |
Completed |
NCT01803581 -
A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice
|
N/A | |
Completed |
NCT01068158 -
A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
|
Phase 3 | |
Completed |
NCT01066585 -
A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation
|
Phase 3 | |
Completed |
NCT00857935 -
A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse
|
Phase 2 | |
Completed |
NCT00301340 -
Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice
|
Phase 3 | |
Completed |
NCT02061813 -
Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion
|
Phase 1 | |
Completed |
NCT02062073 -
Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion
|
Phase 1 | |
Completed |
NCT00605956 -
NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00479310 -
Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice
|
Phase 3 |